Patents by Inventor Stephen Daniel WAX

Stephen Daniel WAX has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS RELATED TO THE TREATMENT OF IGA NEPHROPATHY
    Publication number: 20260256882
    Abstract: The present disclosure relates to methods related to the treatment of IgA nephropathy. More specifically, the present disclosure relates to methods for treating a patient having IgA nephropathy (IgAN), to methods for reducing the serum Gd-IgA1 level in a patient having IgA nephropathy (IgAN), to methods for reducing the proteinuria in a patient having IgA nephropathy, to methods for reducing the serum Gd-IgA1 level and the proteinuria in a patient having IgA nephropathy, and further related disclosure.
    Type: Application
    Filed: January 28, 2026
    Publication date: September 3, 2026
    Inventors: Stephen Daniel WAX, Roberto BASSI, Hans GUEHRING, Christopher TEHLIRIAN, Amy Hui-Chien KAO
  • METHODS RELATED TO THE TREATMENT OF IGA NEPHROPATHY
    Publication number: 20260256884
    Abstract: The present disclosure relates to methods related to the treatment of IgA nephropathy. More specifically, the present disclosure relates to methods for treating a patient having IgA nephropathy (IgAN), to methods for reducing the serum Gd-IgA1 level in a patient having IgA nephropathy (IgAN), to methods for reducing the proteinuria in a patient having IgA nephropathy, to methods for reducing the serum Gd-IgA1 level and the proteinuria in a patient having IgA nephropathy, and further related disclosure.
    Type: Application
    Filed: January 28, 2026
    Publication date: September 3, 2026
    Inventors: Stephen Daniel WAX, Roberto BASSI, Hans GUEHRING, Christopher TEHLIRIAN, Amy Hui-Chien KAO
  • METHODS RELATED TO THE TREATMENT OF IGA NEPHROPATHY
    Publication number: 20260256883
    Abstract: The present disclosure relates to methods related to the treatment of IgA nephropathy. More specifically, the present disclosure relates to methods for treating a patient having IgA nephropathy (IgAN), to methods for reducing the serum Gd-IgA1 level in a patient having IgA nephropathy (IgAN), to methods for reducing the proteinuria in a patient having IgA nephropathy, to methods for reducing the serum Gd-IgA1 level and the proteinuria in a patient having IgA nephropathy, and further related disclosure.
    Type: Application
    Filed: January 28, 2026
    Publication date: September 3, 2026
    Inventors: Stephen Daniel WAX, Roberto BASSI, Hans GUEHRING, Christopher TEHLIRIAN, Amy Hui-Chien KAO
  • Methods related to the treatment of IgA nephropathy
    Patent number: 12661386
    Abstract: The present disclosure relates to methods related to the treatment of IgA nephropathy. More specifically, the present disclosure relates to methods for treating a patient having IgA nephropathy (IgAN), to methods for reducing the serum Gd-IgA1 level in a patient having IgA nephropathy (IgAN), to methods for reducing the proteinuria in a patient having IgA nephropathy, to methods for reducing the serum Gd-IgA1 level and the proteinuria in a patient having IgA nephropathy, and further related disclosure.
    Type: Grant
    Filed: December 2, 2022
    Date of Patent: June 23, 2026
    Assignee: Ares Trading S.A.
    Inventors: Stephen Daniel Wax, Roberto Bassi, Hans Guehring, Christopher Tehlirian, Amy Hui-Chien Kao
  • METHODS RELATED TO THE TREATMENT OF IGA NEPHROPATHY
    Publication number: 20260151456
    Abstract: The present disclosure relates to methods related to the treatment of IgA nephropathy. More specifically, the present disclosure relates to methods for treating a patient having IgA nephropathy (IgAN), to methods for reducing the serum Gd-IgA1 level in a patient having IgA nephropathy (IgAN), to methods for reducing the proteinuria in a patient having IgA nephropathy, to methods for reducing the serum Gd-IgA1 level and the proteinuria in a patient having IgA nephropathy, and further related disclosure.
    Type: Application
    Filed: January 28, 2026
    Publication date: June 4, 2026
    Inventors: Stephen Daniel WAX, Roberto BASSI, Hans GUEHRING, Christopher TEHLIRIAN, Amy Hui-Chien KAO
  • METHODS RELATED TO THE TREATMENT OF IGA NEPHROPATHY
    Publication number: 20250170213
    Abstract: The present disclosure relates to methods related to the treatment of IgA nephropathy. More specifically, the present disclosure relates to methods for treating a patient having IgA nephropathy (IgAN), to methods for reducing the serum Gd-IgA1 level in a patient having IgA nephropathy (IgAN), to methods for reducing the proteinuria in a patient having IgA nephropathy, to methods for reducing the serum Gd-IgA1 level and the proteinuria in a patient having IgA nephropathy, and further related disclosure.
    Type: Application
    Filed: February 14, 2025
    Publication date: May 29, 2025
    Inventors: Stephen Daniel WAX, Roberto BASSI, Hans GUEHRING, Christopher TEHLIRIAN, Amy Hui-Chien KAO
  • METHODS RELATED TO THE TREATMENT OF IGA NEPHROPATHY
    Publication number: 20230210948
    Abstract: The present disclosure relates to methods related to the treatment of IgA nephropathy. More specifically, the present disclosure relates to methods for treating a patient having IgA nephropathy (IgAN), to methods for reducing the serum Gd-IgA1 level in a patient having IgA nephropathy (IgAN), to methods for reducing the proteinuria in a patient having IgA nephropathy, to methods for reducing the serum Gd-IgA1 level and the proteinuria in a patient having IgA nephropathy, and further related disclosure.
    Type: Application
    Filed: December 2, 2022
    Publication date: July 6, 2023
    Inventors: Stephen Daniel WAX, Roberto BASSI, Hans GUEHRING, Christopher TEHLIRIAN, Amy Hui-Chien KAO